VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer

VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer

10.1158/1535-7163.MCT-12-0466

Saved in:
Bibliographic Details
Main Authors: Hart, S., Novotny-Diermayr, V., Goh, K.C., Williams, M., Tan, Y.C., Ong, L.C., Cheong, A., Ng, B.K., Amalini, C., Madan, B., Nagaraj, H., Jayaraman, R., Pasha, K.M., Ethirajulu, K., Chng, W.J., Mustafa, N., Goh, B.C., Benes, C., McDermott, U., Garnett, M., Dymock, B., Wood, J.M.
Other Authors: MEDICINE
Format: Article
Published: 2016
Online Access:http://scholarbank.nus.edu.sg/handle/10635/125481
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/125481

Similar Items